Construction of a der p2-transgenic plant for the alleviation of airway inflammation

C. C. Lee, H. Ho, K. T. Lee, S. T. Jeng, B. L. Chiang

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In clinical therapy, the amount of antigen administered to achieve oral tolerance for allergic diseases is large, and the cost is a major consideration. In this study, we used tobacco plants to develop a large-scale protein production system for allergen-specific immunotherapy, and we investigated the mechanisms of oral tolerance induced by a transgenic plant-derived antigen. We used plants (tobacco leaves) transgenic for the Dermatophagoides pteronyssinus 2 (Der p2) antigen to produce Der p2. Mice received total protein extract from Der p2 orally once per day over 6 days (days 0-2 and days 6-8). Mice were also sensitized and challenged with yeast-derived recombinant Der p2 (rDer p2), after which the mice were examined for airway hyper-responsiveness and airway inflammation. After sensitization and challenge with rDer p2, mice that were fed with total protein extracted from transgenic plants showed decreases in serum Der p2-specific IgE and IgG1 titers, decreased IL-5 and eotaxin levels in bronchial alveolar lavage fluid, and eosinophil infiltration in the airway. In addition, hyper-responsiveness was also decreased in mice that were fed with total protein extracted from transgenic plants, and CD4 CD25 Foxp3 regulatory T cells were significantly increased in mediastinal and mesenteric lymph nodes. Furthermore, splenocytes isolated from transgenic plant protein-fed mice exhibited decreased proliferation and increased IL-10 secretion after stimulation with rDer p2. The data here suggest that allergen-expressing transgenic plants could be used for therapeutic purposes for allergic diseases.

Original languageEnglish
Pages (from-to)404-414
Number of pages11
JournalCellular and Molecular Immunology
Volume8
Issue number5
DOIs
Publication statusPublished - Sep 1 2011

Fingerprint

Inbred BALB C Mouse
Dermatophagoides pteronyssinus
Dermatophagoides Antigens
Animal Disease Models
Genetically Modified Plants
Interleukin-5
Bronchoalveolar Lavage Fluid
Regulatory T-Lymphocytes
Interleukin-10
Allergens
Immunoglobulin E
Transfection
Plasmids
Asthma
Immunoglobulin G
Lymph Nodes
Enzyme-Linked Immunosorbent Assay
Inflammation
Lung
Tobacco

Keywords

  • asthma
  • Der p2
  • IL-10
  • oral tolerance
  • transgenic plant

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Construction of a der p2-transgenic plant for the alleviation of airway inflammation. / Lee, C. C.; Ho, H.; Lee, K. T.; Jeng, S. T.; Chiang, B. L.

In: Cellular and Molecular Immunology, Vol. 8, No. 5, 01.09.2011, p. 404-414.

Research output: Contribution to journalArticle

@article{e93f3f1c821748cc951c8f33a6c6c5bd,
title = "Construction of a der p2-transgenic plant for the alleviation of airway inflammation",
abstract = "In clinical therapy, the amount of antigen administered to achieve oral tolerance for allergic diseases is large, and the cost is a major consideration. In this study, we used tobacco plants to develop a large-scale protein production system for allergen-specific immunotherapy, and we investigated the mechanisms of oral tolerance induced by a transgenic plant-derived antigen. We used plants (tobacco leaves) transgenic for the Dermatophagoides pteronyssinus 2 (Der p2) antigen to produce Der p2. Mice received total protein extract from Der p2 orally once per day over 6 days (days 0-2 and days 6-8). Mice were also sensitized and challenged with yeast-derived recombinant Der p2 (rDer p2), after which the mice were examined for airway hyper-responsiveness and airway inflammation. After sensitization and challenge with rDer p2, mice that were fed with total protein extracted from transgenic plants showed decreases in serum Der p2-specific IgE and IgG1 titers, decreased IL-5 and eotaxin levels in bronchial alveolar lavage fluid, and eosinophil infiltration in the airway. In addition, hyper-responsiveness was also decreased in mice that were fed with total protein extracted from transgenic plants, and CD4 CD25 Foxp3 regulatory T cells were significantly increased in mediastinal and mesenteric lymph nodes. Furthermore, splenocytes isolated from transgenic plant protein-fed mice exhibited decreased proliferation and increased IL-10 secretion after stimulation with rDer p2. The data here suggest that allergen-expressing transgenic plants could be used for therapeutic purposes for allergic diseases.",
keywords = "asthma, Der p2, IL-10, oral tolerance, transgenic plant",
author = "Lee, {C. C.} and H. Ho and Lee, {K. T.} and Jeng, {S. T.} and Chiang, {B. L.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1038/cmi.2011.13",
language = "English",
volume = "8",
pages = "404--414",
journal = "Cellular and Molecular Immunology",
issn = "1672-7681",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Construction of a der p2-transgenic plant for the alleviation of airway inflammation

AU - Lee, C. C.

AU - Ho, H.

AU - Lee, K. T.

AU - Jeng, S. T.

AU - Chiang, B. L.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - In clinical therapy, the amount of antigen administered to achieve oral tolerance for allergic diseases is large, and the cost is a major consideration. In this study, we used tobacco plants to develop a large-scale protein production system for allergen-specific immunotherapy, and we investigated the mechanisms of oral tolerance induced by a transgenic plant-derived antigen. We used plants (tobacco leaves) transgenic for the Dermatophagoides pteronyssinus 2 (Der p2) antigen to produce Der p2. Mice received total protein extract from Der p2 orally once per day over 6 days (days 0-2 and days 6-8). Mice were also sensitized and challenged with yeast-derived recombinant Der p2 (rDer p2), after which the mice were examined for airway hyper-responsiveness and airway inflammation. After sensitization and challenge with rDer p2, mice that were fed with total protein extracted from transgenic plants showed decreases in serum Der p2-specific IgE and IgG1 titers, decreased IL-5 and eotaxin levels in bronchial alveolar lavage fluid, and eosinophil infiltration in the airway. In addition, hyper-responsiveness was also decreased in mice that were fed with total protein extracted from transgenic plants, and CD4 CD25 Foxp3 regulatory T cells were significantly increased in mediastinal and mesenteric lymph nodes. Furthermore, splenocytes isolated from transgenic plant protein-fed mice exhibited decreased proliferation and increased IL-10 secretion after stimulation with rDer p2. The data here suggest that allergen-expressing transgenic plants could be used for therapeutic purposes for allergic diseases.

AB - In clinical therapy, the amount of antigen administered to achieve oral tolerance for allergic diseases is large, and the cost is a major consideration. In this study, we used tobacco plants to develop a large-scale protein production system for allergen-specific immunotherapy, and we investigated the mechanisms of oral tolerance induced by a transgenic plant-derived antigen. We used plants (tobacco leaves) transgenic for the Dermatophagoides pteronyssinus 2 (Der p2) antigen to produce Der p2. Mice received total protein extract from Der p2 orally once per day over 6 days (days 0-2 and days 6-8). Mice were also sensitized and challenged with yeast-derived recombinant Der p2 (rDer p2), after which the mice were examined for airway hyper-responsiveness and airway inflammation. After sensitization and challenge with rDer p2, mice that were fed with total protein extracted from transgenic plants showed decreases in serum Der p2-specific IgE and IgG1 titers, decreased IL-5 and eotaxin levels in bronchial alveolar lavage fluid, and eosinophil infiltration in the airway. In addition, hyper-responsiveness was also decreased in mice that were fed with total protein extracted from transgenic plants, and CD4 CD25 Foxp3 regulatory T cells were significantly increased in mediastinal and mesenteric lymph nodes. Furthermore, splenocytes isolated from transgenic plant protein-fed mice exhibited decreased proliferation and increased IL-10 secretion after stimulation with rDer p2. The data here suggest that allergen-expressing transgenic plants could be used for therapeutic purposes for allergic diseases.

KW - asthma

KW - Der p2

KW - IL-10

KW - oral tolerance

KW - transgenic plant

UR - http://www.scopus.com/inward/record.url?scp=80052516050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052516050&partnerID=8YFLogxK

U2 - 10.1038/cmi.2011.13

DO - 10.1038/cmi.2011.13

M3 - Article

VL - 8

SP - 404

EP - 414

JO - Cellular and Molecular Immunology

JF - Cellular and Molecular Immunology

SN - 1672-7681

IS - 5

ER -